Explore Solutions for Combatting AMR

Through our expertise and strategic partnerships, we are pushing boundaries with next-generation technologies to improve workflow and drive confidence in patient results. Our gold-standard accuracy helps laboratories stay ahead of rising demands. Preview our solutions below.

In‑Booth Scientific Presentations

Featuring scientific talks presented by key opinion leaders, in collaboration with Danaher, Beckman Coulter, and Cepheid.

Visit the Danaher booth for short scientific presentations delivered during congress breaks. These in‑booth sessions provide focused scientific insights and opportunities for discussion with experts from Danaher, Beckman Coulter, Cepheid, and Cytiva, in an informal and accessible setting.

Saturday 18 April 2026
10:30 – 11:00 Case Study: Optimizing Urine Section Workflow with Beckman Coulter Autoplak

Alan Spratt, Head of Department, Infectious Sciences, Health Services Laboratories (HSL), London, UK [In collaboration with Beckman Coulter]

15:45 - 16:15 The Role of Rapid Molecular Diagnostics in Infection Prevention and Control for Tackling Antimicrobial Resistance in

European Hospitals
Dr Rafael Cantón, Head of the Clinical Microbiology Department at Ramón y Cajal University Hospital and Associate Professor of Clinical Microbiology at Complutense University, Madrid.

Vanessa Carter, Patient with Lived Experience of AMR and Advocate, Executive Director of The AMR Narrative, UK [In collaboration with Cepheid]

Sunday 19 April 2026
10:30 - 11:00 Difficulties cum Clostridioides difficile infections

Dr Michael Perry, Deputy Lead Scientist, UK Anaerobe Reference Unit Public Health Wales Microbiology, Cardiff, UK [In collaboration with Cepheid]

15:45 - 16:15 The Future of Diagnostics Innovation at Danaher

Dr Ephraim Tsalik, Vice President and Chief Scientific Officer, Danaher, USA [In collaboration with Danaher]

Monday 20 April 2026
10:30 – 11:00 Precision in Action: Danaher’s Role in Improving Infection Management and Patient Outcomes

Dr. Stephanie Mitchell - Scientific Affairs, Beckman Coulter, USA Dr. Michael Loeffelholz – Vice President Scientific Affairs, Cepheid, USA [In collaboration with Beckman Coulter and Cepheid]

15:45 - 16:15 Improving Patient Flow in the Emergency Department Through Implementation of Rapid PCR Point-of-Care Testing for Respiratory Viruses at Tertiary Care Center, Saudi Arabia: a before-and-after Quality Project

Dr. Malak Almashali, Consultant Clinical Scientist, Head of the POCT, Division at Prince Sultan Military Medical City, Central Laboratory & Blood Bank, Riyadh, and Point of Care Testing Program Project Leader at the Health Support Service Center, Ministry of Health, Saudi Arabia [In collaboration with Cepheid]

Scientific Symposia Program

Featuring expert‑led sessions from Danaher, Cepheid and Beckman Coulter

Advance diagnostic stewardship with sessions that connect testing strategy to clinical action. Hear expert perspectives on choosing the right modality, integrating results into workflows, and improving cost and care outcomes, including discussions spanning multiplex, NGS, and metagenomics.

DANAHER INTEGRATED SYMPOSIUM

From Emerging Threats to Diagnostic Breakthroughs: A Strategic Look Ahead In AMR

Sunday April 19th, 2026, 08:30 - 10 am

08:30 AM Welcome and Introduction
Organiser-appointed Chair: Ephraim Tsalik, MD, MHS, Ph.D. Vice President and Chief Scientific Officer- Infectious Disease & Acute Care, Danaher Diagnostics Group Durham, USA

08:40 AM Talk 1: From MRSA to C. auris: Lessons Learned Across Two Decades of MDRO Surveillance
Dr. David Jenkins, Consultant in Medical Microbiology and Virology & Lead Infection Control Doctor, University Hospitals of Leicester NHS Trust, UK

08:55 AM Talk 2: Recent Advances in Molecular Diagnostics for the Rapid Detection of Antibiotic Resistances in Gram Negatives Pr. Patrice Nordmann, TBD

09:10 AM Talk 3: Beyond diagnostic accuracy: understanding clinician behaviour to improve biomarker- guided antibiotic decisions
Pr. Enitan Carrol, TBD

09:25 AM Talk 4: Rapid MIC Testing: Fact or Fiction
Dr. Romney Humphries,PhD, D(ABMM), Professor in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, Nashville Tennessee, USA

09:40 AM Panel Discussion & QA

CEPHEID INTEGRATED SYMPOSIUM

Precision vs Power: Smarter Panels and the Path to Metagenomics

Monday April 20th, 2026, 8:30 - 10 am

08:30 AM Welcome and Introduction
Organiser-appointed Chair: Christophe Rodriguez, PharmD, PhD, Head of the GenoBioMics Platform, Metagenomic Reference Laboratory, Henri Mondor Hospital, Créteil, France

08:35 AM Talk 1: Pathways to Better Care: Diagnostic Stewardship and Future Innovation
Connie Savor, MD, MBA, Chief Medical Officer, Cepheid, Sunnyvale, USA

08:50 AM Talk 2: Taking Action from Respiratory Pathogen Testing: Real World Lessons
Dr. Cristina Russo, Head of Virology and Mycobacteria Unit, Bambino Gesù Pediatric Hospital, Rome, Italy

09:10 AM Talk 3: Multiplex Molecular Testing for Diagnosis of GI infections: an American Commercial Reference Laboratory Experience
Dr. Gerald A. Capraro, Ph.D, D(ABMM, Technical Director, Routine and Esoteric Microbiology, Labcorp, Burlington, USA

09:30 AM Talk 4: Pathogen Genomics: Redefining Infection Management for Modern Healthcare
Dr. James Price, Associate Professor in Infection, Department of Global Health and Infection, Brighton and Sussex Medical School, UK, Brighton, United Kingdom

09:50 AM Panel Discussion & QA